"Our vaccine has been approved in 40 countries." New vaccine offers hope in fight against disease that threatens half of ...

Takeda announced Tuesday that it has voluntarily withdrawn its application to the Food and Drug Administration for its dengue vaccine, making it unclear when or if the vaccine will be licensed in ...

Takeda's new dengue vaccine, TAK-003, has received prequalification from the World Health Organization (WHO). TAK-003 is the second dengue vaccine to achieve this status. WHO has recommended the ...

Takeda has unexpectedly withdrawn its marketing application with the FDA for dengue fever vaccine TAK-003 and said it will reconsider whether it will attempt to bring it to market in the US.

Takeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says Much like COVID-19, an epidemic like dengue can be a big problem for governments, not just individuals.

Japan's Takeda has secured its first regulatory approval – in Indonesia – for its dengue fever vaccine TAK-003, which has been tipped as a potential blockbuster product.

Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue. WHO recommends using TAK-003 in children aged 6–16 in ...

After decades of delays, the first vaccine for dengue fever was introduced seven ... spurring researchers at Japan’s Takeda Pharmaceutical Co. to redouble efforts on an alternative.

Oct 14 (Reuters) - The European drugs regulator on Friday recommended a dengue vaccine from Japan's Takeda, paving the way for a second vaccine for the mosquito-borne disease that causes millions ...

For years, Takeda has been working hard to bring the first travel vaccine for dengue fever to the market. Now, the company can breathe a sigh of relief as the program snagged an approval from the ...

American depositary receipts of Takeda Pharmaceutical Co. JP:4502 TAK rose more than 1% in the extended session Tuesday after the Japan-based company said its dengue vaccine got the recommendation ...

Takeda Pharmaceutical Co.’s experimental dengue vaccine won the backing of a European Union advisory panel, paving the way for the product to be widely used against the mosquito-borne infection ...